Haemonetics Corporation (HAE) — Strategic Asset Allocation Index
Haemonetics Corporation (HAE) has a Strategic Asset Allocation Index of 32.6% as of December 2025. Strategic assets (PP&E of $297.23 Million plus long-term investments of $-) total $297.23 Million, measured against net assets of $911.45 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Haemonetics Corporation Strategic Asset Allocation Index (2000–2025)
This chart shows how Haemonetics Corporation's Strategic Asset Allocation Index has evolved across 26 annual periods from 2000 to 2025. As of December 2025, the index stands at 32.6%, representing strategic assets of $297.23 Million against net assets of $911.45 Million USD. Explore HAE cash generation efficiency to assess how effectively this company generates cash.
Annual Strategic Asset Allocation Index for Haemonetics Corporation (2000–2025)
The table below presents the year-by-year Strategic Asset Allocation Index for Haemonetics Corporation from 2000 to 2025, covering 26 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see HAE market cap overview.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 40.4% | $331.54 Million | $331.54 Million | $- | $820.84 Million | ▲ +2.2 pp |
| 2024 | 38.2% | $366.63 Million | $366.63 Million | $- | $959.96 Million | ▲ +0.2 pp |
| 2023 | 38.0% | $310.88 Million | $310.88 Million | $- | $818.00 Million | ▲ +3.5 pp |
| 2022 | 34.5% | $258.48 Million | $258.48 Million | $- | $749.42 Million | ▼ -3.4 pp |
| 2021 | 37.9% | $277.42 Million | $277.42 Million | $- | $731.67 Million | ▼ -5.2 pp |
| 2020 | 43.2% | $253.40 Million | $253.40 Million | $- | $587.11 Million | ▼ -8.3 pp |
| 2019 | 51.5% | $343.98 Million | $343.98 Million | $- | $667.87 Million | ▲ +7.4 pp |
| 2018 | 44.1% | $332.16 Million | $332.16 Million | $- | $752.43 Million | ▲ +0.4 pp |
| 2017 | 43.8% | $323.86 Million | $323.86 Million | $- | $739.61 Million | ▼ -3.1 pp |
| 2016 | 46.9% | $337.63 Million | $337.63 Million | $- | $719.98 Million | ▲ +7.9 pp |
| 2015 | 39.0% | $321.95 Million | $321.95 Million | $- | $826.12 Million | ▲ +6.6 pp |
| 2014 | 32.3% | $271.44 Million | $271.44 Million | $- | $839.61 Million | ▼ -1.1 pp |
| 2013 | 33.4% | $256.95 Million | $256.95 Million | $- | $769.18 Million | ▲ +11.4 pp |
| 2012 | 22.0% | $161.66 Million | $161.66 Million | $- | $735.08 Million | ▼ -0.7 pp |
| 2011 | 22.7% | $155.53 Million | $155.53 Million | $- | $686.14 Million | ▼ -3.2 pp |
| 2010 | 25.8% | $153.30 Million | $153.30 Million | $- | $593.12 Million | ▲ +0.3 pp |
| 2009 | 25.5% | $137.81 Million | $137.81 Million | $- | $539.88 Million | ▲ +2.0 pp |
| 2008 | 23.6% | $116.48 Million | $116.48 Million | $- | $494.19 Million | ▲ +4.6 pp |
| 2007 | 18.9% | $90.78 Million | $90.78 Million | $- | $479.65 Million | ▲ +1.9 pp |
| 2006 | 17.0% | $75.27 Million | $75.27 Million | $- | $441.65 Million | ▼ -2.5 pp |
| 2005 | 19.5% | $69.34 Million | $69.34 Million | $- | $355.13 Million | ▼ -8.4 pp |
| 2004 | 27.9% | $78.03 Million | $78.03 Million | $- | $279.75 Million | ▼ -9.7 pp |
| 2003 | 37.6% | $83.99 Million | $83.99 Million | $- | $223.24 Million | ▲ +1.8 pp |
| 2002 | 35.8% | $84.88 Million | $84.88 Million | $- | $236.82 Million | ▼ -2.8 pp |
| 2001 | 38.6% | $83.25 Million | $83.25 Million | $- | $215.52 Million | ▼ -0.9 pp |
| 2000 | 39.5% | $81.61 Million | $81.61 Million | $- | $206.44 Million | — |